2005
DOI: 10.1038/nrg1577
|View full text |Cite
|
Sign up to set email alerts
|

Towards safe, non-viral therapeutic gene expression in humans

Abstract: The potential dangers of using viruses to deliver and integrate DNA into host cells in gene therapy have been poignantly highlighted in recent clinical trials. Safer, non-viral gene delivery approaches have been largely ignored in the past because of their inefficient delivery and the resulting transient transgene expression. However, recent advances indicate that efficient, long-term gene expression can be achieved by non-viral means. In particular, integration of DNA can be targeted to specific genomic sites… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
412
0
7

Year Published

2005
2005
2017
2017

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 539 publications
(421 citation statements)
references
References 145 publications
2
412
0
7
Order By: Relevance
“…This is of particular relevance to the development of "artificial viruses" (AVs), in which there is considerable research interest owing to the identification of significant pathogenesis in viral-mediated gene delivery/gene therapy trials (Glover et al, 2005;Mastrobattista et al, 2006b). Nonviral approaches should provide a safe alternative to viral gene delivery, but are believed to be inefficient, largely owing to the poor nuclear delivery of DNA (Chan and Jans, 2002;Glover et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This is of particular relevance to the development of "artificial viruses" (AVs), in which there is considerable research interest owing to the identification of significant pathogenesis in viral-mediated gene delivery/gene therapy trials (Glover et al, 2005;Mastrobattista et al, 2006b). Nonviral approaches should provide a safe alternative to viral gene delivery, but are believed to be inefficient, largely owing to the poor nuclear delivery of DNA (Chan and Jans, 2002;Glover et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Nonviral approaches should provide a safe alternative to viral gene delivery, but are believed to be inefficient, largely owing to the poor nuclear delivery of DNA (Chan and Jans, 2002;Glover et al, 2005). AVs are intended to overcome these problems by incorporating modules that mimic efficient nuclear targeting by viruses (e.g., cell-specific binding/uptake, endosomal escape, and nuclear import; Cohen et al, 2005;Glover et al, 2005;Alvisi et al, 2006; Mastrobattista et al, 2006a,b), while avoiding the pathogenicity associated with viral approaches. We have successfully utilized modular approaches to achieve nuclear drug delivery relevant to chemotherapy (Rosenkranz et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, challenges in developing safe and efficacious gene transfer vectors have limited its clinical application. Synthetic non-viral gene transfer vectors are being developed as alternatives to viral vectors (Glover et al, 2005). Among non-viral gene delivery systems under development are electrostatic complexes derived from cationic liposomes (lipoplexes) (Felgner et al, 1987;Gao and Huang, 1991), cationic polymers (polyplexes) (Boussif et al, 1995;Pack et al, 2005), and lipid-polymer-DNA (LPD) ternary complexes (lipopolyplexes) (Gao and Huang, 1996;Guo et al, 2002;Lee and Huang, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…Generally, viral (e.g., adenoviruses, lentiviruses and retroviruses) and nonviral vectors (e.g., lipids and polymers) can be used for cellular transfection and/or nucleofection, thus offering durable gene expression within stem cells [93][94][95][96]. Nonviral carriers have a number of advantages over viral vectors, since they exhibit low-risk immunogenicity and insertional mutagenesis, controllable toxicity, and excellent gene-carrying capacity [95]. Many efforts for the improvement of nonviral vectors are focused on cationic polymers that interact with negatively charged DNA or RNAi.…”
Section: A U T H O R P R O O Fmentioning
confidence: 99%